Shanghai Innostar Bio-Tech Co Ltd Sustainability Reports
The company operates as a biopharmaceutical contract research organization (CRO) providing non-clinical research and development services. Its services include early-stage druggability assessment, non-clinical safety evaluation, and pharmacokinetic and pharmacodynamic research.
Sector: Professional & technical services
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG01MN81SK2
2 reports from 2024 to 2025